Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?

As of May 2022, there have been more than 500 million confirmed cases of COVID-19.  Additionally, more than 5 billion people have received at least one dose of a COVID-19 vaccine. Immune responses to natural COVID-19 infections, including to the numerous variants and subvariants, and to the variety of available vaccines are unique.

 

Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.

 

Bio-Rad SARS-CoV-2 products provide you and your laboratory with efficient new ways to quantitatively characterize immune responses.

 

Learning Objectives